- Home
- ITIC vs RLAY Comparison
ITIC vs RLAY Comparison
Compare ITIC & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ITIC | RLAY |
|---|---|---|
| Founded | 1972 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 517.1M | 1.4B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | ITIC | RLAY |
|---|---|---|
| Price | $251.96 | $8.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 19.3K | ★ 2.3M |
| Earning Date | 02-12-2026 | 11-06-2025 |
| Dividend Yield | ★ 6.30% | N/A |
| EPS Growth | ★ 25.81 | N/A |
| EPS | ★ 19.00 | N/A |
| Revenue | ★ $273,864,000.00 | $8,355,000.00 |
| Revenue This Year | N/A | $20.47 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.23 | ★ N/A |
| Revenue Growth | ★ 13.63 | N/A |
| 52 Week Low | $190.20 | $1.78 |
| 52 Week High | $288.98 | $9.04 |
Technical Indicators
Market Signals| Indicator | ITIC | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 44.53 | 63.83 |
| Support Level | $250.26 | $8.13 |
| Resistance Level | $260.66 | $8.81 |
| Average True Range (ATR) | 7.32 | 0.51 |
| MACD | 0.30 | 0.02 |
| Stochastic Oscillator | 51.41 | 75.93 |
Price Performance
Historical ComparisonAbout ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).